'Iran is a cancer': Iranian-born CEO takes on the regime

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

'Iran is a cancer': Iranian-born CEO takes on the regime

無料で聴く

ポッドキャストの詳細を見る

Iranian-born and married into a Jewish family, NeOnc CEO Amir Heshmatpour says he's fighting cancer on two fronts, the brain, and the Iranian regime. In this Jerusalem Post interview, Heshmatpour tells news editor Alex Winston how the Islamic Republic jailed and tortured his father, who died at 46, the loss that shaped his life.

He explains why he calls the regime "a cancer in this part of the world," and describes being in Israel during the 12-day war with Iran. He also lays out the science behind NeOnc (Nasdaq: NTHI): an intranasal delivery platform, protected by more than 179 patents, that bypasses the blood-brain barrier to treat aggressive brain tumors.

"I'm fighting cancer on two fronts," says Heshmatpour, "one for the brain and one for the Iranian people." It's a rare vantage point, a Persian entrepreneur from Tabriz, now a Los Angeles biotech executive, who wants trials running at Sheba and Tel Aviv alongside sites in the US and UAE, and who talks openly about the Abraham Accords, a hoped-for "Cyrus Accords," and what a post-regime Iran could look like.

Whether you follow Middle East politics, diaspora Jewish affairs, or the business of biotech, this conversation sits at the intersection of all three.

まだレビューはありません